Viewing Study NCT06732960


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2026-01-04 @ 1:21 AM
Study NCT ID: NCT06732960
Status: COMPLETED
Last Update Posted: 2025-04-02
First Post: 2024-12-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Efficacy and Safety of Efsubaglutide Alfa in Overweight or Obesity Patients
Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-04-21
Start Date Type: ACTUAL
Primary Completion Date: 2024-11-18
Primary Completion Date Type: ACTUAL
Completion Date: 2024-11-18
Completion Date Type: ACTUAL
First Submit Date: 2024-12-05
First Submit QC Date: None
Study First Post Date: 2024-12-13
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-04-01
Last Update Post Date: 2025-04-02
Last Update Post Date Type: ACTUAL